Navigation Links
Avantium Launches the Crystalline, a New Parallel System for Crystallization Research
Date:1/22/2009

AMSTERDAM, January 22 /PRNewswire/ -- Avantium Technologies announces the launch of a new system to study crystallization processes for the pharmaceutical industry. The system will be marketed under the name Crystalline.

The Crystalline has been designed to address the need in the pharma industry to learn as much as possible about a drug candidate early in the development cycle.

"Avantium is proud to launch its next system in crystallization research. The Crystalline follows the success of our Crystal16TM, that is used by all Top 20 pharma companies", commented Tom van Aken, CEO of Avantium. "We are excited about the positive feedback of our customers to the new features and advanced analytics of our new Crystalline."

The Crystalline enables easy access for scientists to valuable information on drug candidates, when only a limited amount of sample is available. Bench chemists can use in situ analytics, on a milliliter scale: visualization through the vial (on-board camera's and particle analysis software) and real time Raman spectroscopy.

Crystalline is a small volume parallel crystallizer with overhead stirring and refluxing capabilities. The system and software have been designed by scientists who perform crystallization experiments on a daily basis, making it easy to program and operate.

The system can be customized, combining turbidity information with a parallel particle viewer or with real time Raman capabilities, shedding light on chemical reactions, crystallization processes, polymorph conversions, salt or co-crystal formation.

About Avantium

Avantium is a leading technology company in the area of advanced high-throughput R&D operating in the energy, chemicals and pharmaceutical industries. The company develops products and processes in the area of biofuels, bio-based chemicals and novel crystal forms of existing drugs by applying its proprietary, high-throughput R&D technology.

Avantium has demonstrated the potential of this technology by providing R&D services and tools to more than 70 companies worldwide. Avantium's customer base includes many of the world's largest energy, chemicals and pharmaceutical companies, such as BP, Shell, Sasol, Pfizer and GSK. Avantium has approximately 140 employees; its offices and head quarters are based in Amsterdam, the Netherlands.

http://www.avantium.com/crystalline


'/>"/>
SOURCE Avantium Technologies B.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cosun and Avantium Announce Collaboration
2. Avantium Completes EUR 18 Million Financing Round
3. Jubilant Biosys Launches Legend NGSS(TM) Advanced Software Solution for High-Throughput Drug Molecule Screening
4. Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel
5. Cain and Associates Launches Government Audit Protection (GAP) Service
6. Innovative Beverage Products Launches New Product Designed to Enhance the Bodys Immune Defense
7. WellCentive Launches New Health Information Exchange Platforms
8. DaVita Launches Flu Fighter Program in Support of National Influenza Week
9. Techstreet Launches BuildingBlocks Utility for Industry Standards Saving Time and Increasing Productivity for Engineers
10. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
11. Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
Breaking Biology Technology:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/14/2016)... , April 14, 2016 ... Malware Detection, today announced the appointment of Eyal ... new role. Goldwerger,s leadership appointment comes at ... heels of the deployment of its platform at several ... biometric technology, which discerns unique cognitive and physiological factors, ...
Breaking Biology News(10 mins):